
Kevin M. Picardat
Examiner (ID: 9381, Phone: (571)272-1841 , Office: P/2822 )
| Most Active Art Unit | 2822 |
| Art Unit(s) | 2813, 2825, 1104, 2899, 2822, 1763, 1732 |
| Total Applications | 2640 |
| Issued Applications | 2463 |
| Pending Applications | 47 |
| Abandoned Applications | 134 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5807240
[patent_doc_number] => 20060093594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions'
[patent_app_type] => utility
[patent_app_number] => 11/293565
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23093
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093594.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293565
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293565 | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions | Dec 1, 2005 | Issued |
Array
(
[id] => 5063570
[patent_doc_number] => 20070225210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Therapeutic vaccine compositions for the treatment of type 1 diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/293585
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3838
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293585
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293585 | Therapeutic vaccine compositions for the treatment of type 1 diabetes | Dec 1, 2005 | Abandoned |
Array
(
[id] => 5236069
[patent_doc_number] => 20070128226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Methods of treating pain associated with abnormalities of the first metatarsophalangeal joint of the foot'
[patent_app_type] => utility
[patent_app_number] => 11/292200
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4366
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128226.pdf
[firstpage_image] =>[orig_patent_app_number] => 11292200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/292200 | Methods of treating pain associated with abnormalities of the first metatarsophalangeal joint of the foot | Nov 30, 2005 | Abandoned |
Array
(
[id] => 5501653
[patent_doc_number] => 20090162341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'Non-Cytotoxic Protein Conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/791979
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 28462
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20090162341.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791979 | Non-cytotoxic protein conjugates | Nov 30, 2005 | Issued |
Array
(
[id] => 274268
[patent_doc_number] => 07560432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'In situ method for treatment and repair of meniscal injuries'
[patent_app_type] => utility
[patent_app_number] => 11/285928
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 8575
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560432.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285928
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285928 | In situ method for treatment and repair of meniscal injuries | Nov 22, 2005 | Issued |
Array
(
[id] => 5596802
[patent_doc_number] => 20060160720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Protein stabilization in solution'
[patent_app_type] => utility
[patent_app_number] => 11/284709
[patent_app_country] => US
[patent_app_date] => 2005-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11507
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160720.pdf
[firstpage_image] =>[orig_patent_app_number] => 11284709
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284709 | Protein stabilization in solution | Nov 21, 2005 | Issued |
Array
(
[id] => 373457
[patent_doc_number] => 07473760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Cyclic peptide compositions for treatment of sexual dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/269271
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17326
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11269271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/269271 | Cyclic peptide compositions for treatment of sexual dysfunction | Nov 8, 2005 | Issued |
Array
(
[id] => 131695
[patent_doc_number] => 07700544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-20
[patent_title] => 'Compositions and methods for treating atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/268690
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 26993
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/700/07700544.pdf
[firstpage_image] =>[orig_patent_app_number] => 11268690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/268690 | Compositions and methods for treating atherosclerosis | Nov 6, 2005 | Issued |
Array
(
[id] => 5835345
[patent_doc_number] => 20060247176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins'
[patent_app_type] => utility
[patent_app_number] => 11/268757
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10304
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247176.pdf
[firstpage_image] =>[orig_patent_app_number] => 11268757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/268757 | Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus neurotoxins | Nov 3, 2005 | Issued |
Array
(
[id] => 455724
[patent_doc_number] => 07244436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Clostridial toxin derivatives and methods for treating pain'
[patent_app_type] => utility
[patent_app_number] => 11/265953
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13091
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244436.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265953 | Clostridial toxin derivatives and methods for treating pain | Nov 2, 2005 | Issued |
Array
(
[id] => 436034
[patent_doc_number] => 07262291
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Clostridial toxin derivatives and methods for treating pain'
[patent_app_type] => utility
[patent_app_number] => 11/265823
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13082
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262291.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265823
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265823 | Clostridial toxin derivatives and methods for treating pain | Nov 2, 2005 | Issued |
Array
(
[id] => 5807271
[patent_doc_number] => 20060093625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Clostridial toxin derivatives and methods for treating pain'
[patent_app_type] => utility
[patent_app_number] => 11/265988
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12585
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093625.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265988
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265988 | Clostridial toxin derivatives and methods for treating pain | Nov 2, 2005 | Issued |
Array
(
[id] => 5672490
[patent_doc_number] => 20060177845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'UBP1 protease mutant, and its coding sequence, their application and methods of production'
[patent_app_type] => utility
[patent_app_number] => 11/265532
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 3128
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177845.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265532 | UBP1 protease mutant, and its coding sequence, their application and methods of production | Oct 31, 2005 | Issued |
Array
(
[id] => 5682971
[patent_doc_number] => 20060199241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Electrochemically and optically monitoring cleaving enzyme activity'
[patent_app_type] => utility
[patent_app_number] => 11/264288
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5944
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199241.pdf
[firstpage_image] =>[orig_patent_app_number] => 11264288
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/264288 | Electrochemically and optically monitoring cleaving enzyme activity | Oct 31, 2005 | Abandoned |
Array
(
[id] => 5866004
[patent_doc_number] => 20060100135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Compositions and methods for modifying toxic effects of proteinaceous compounds'
[patent_app_type] => utility
[patent_app_number] => 11/263537
[patent_app_country] => US
[patent_app_date] => 2005-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30732
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100135.pdf
[firstpage_image] =>[orig_patent_app_number] => 11263537
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/263537 | Compositions and methods for modifying toxic effects of proteinaceous compounds | Oct 30, 2005 | Issued |
Array
(
[id] => 5590861
[patent_doc_number] => 20060040312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Uses of kappa-conotoxin PVIIA'
[patent_app_type] => utility
[patent_app_number] => 11/259039
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10834
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259039
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259039 | Uses of kappa-conotoxin PVIIA | Oct 26, 2005 | Abandoned |
Array
(
[id] => 83193
[patent_doc_number] => 07741070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Gene targets for enhanced carotenoid production'
[patent_app_type] => utility
[patent_app_number] => 11/259745
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31347
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 204
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11259745
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/259745 | Gene targets for enhanced carotenoid production | Oct 26, 2005 | Issued |
Array
(
[id] => 4583682
[patent_doc_number] => 07851441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-14
[patent_title] => 'Water-soluble elastin, process for producing same, and food and medicine containing same'
[patent_app_type] => utility
[patent_app_number] => 11/666443
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13348
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/851/07851441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11666443
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666443 | Water-soluble elastin, process for producing same, and food and medicine containing same | Oct 26, 2005 | Issued |
Array
(
[id] => 5842276
[patent_doc_number] => 20060121056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics'
[patent_app_type] => utility
[patent_app_number] => 11/257500
[patent_app_country] => US
[patent_app_date] => 2005-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12463
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 46
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121056.pdf
[firstpage_image] =>[orig_patent_app_number] => 11257500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/257500 | Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics | Oct 24, 2005 | Issued |
Array
(
[id] => 5743580
[patent_doc_number] => 20060089305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Compositions and methods for activating toll-like receptor 4'
[patent_app_type] => utility
[patent_app_number] => 11/248085
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3582
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20060089305.pdf
[firstpage_image] =>[orig_patent_app_number] => 11248085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/248085 | Compositions and methods for activating toll-like receptor 4 | Oct 11, 2005 | Abandoned |